Defective control of pre-messenger RNA splicing in human disease
about
Modulating splicing with small molecular inhibitors of the spliceosomeThe nuts and bolts of the endogenous spliceosomeOxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy GeneMicrobial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer TreatmentStructural insights into Gemin5-guided selection of pre-snRNAs for snRNP assemblyMutations in spliceosomal proteins and retina degenerationThe notorious R.N.A. in the spotlight - drug or target for the treatment of diseaseEventPointer: an effective identification of alternative splicing events using junction arrays.Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.Structural studies of the endogenous spliceosome - The supraspliceosome.A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferationSplice-switching antisense oligonucleotides as therapeutic drugsThe determinants of alternative RNA splicing in human cells.BPP: a sequence-based algorithm for branch point prediction.Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.Variant in the X-chromosome spliceosomal gene GPKOW causes male-lethal microcephaly with intrauterine growth restriction.Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.RNA splicing during terminal erythropoiesis.Integration of mRNP formation and export.Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.Alternative splicing as a regulator of development and tissue identity.Deep intronic mutations and human disease.The emerging role of alternative splicing in senescence and aging.From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides.Cutting a Long Intron Short: Recursive Splicing and Its Implications.The role of alternative splicing in cancer.RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.Circular RNAs in cancer: opportunities and challenges in the field.Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.MYC Regulates α6 Integrin Subunit Expression and Splicing Under Its Pro-Proliferative ITGA6A Form in Colorectal Cancer Cells.Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: application to titin.The TORC1-Regulated CPA Complex Rewires an RNA Processing Network to Drive Autophagy and Metabolic Reprogramming.Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4.ZFR coordinates crosstalk between RNA decay and transcription in innate immunity.Alternative mRNA Splicing in the Pathogenesis of Obesity.Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.Multilevel Differential Control of Hormone Gene Expression Programs by hnRNP L and LL in Pituitary Cells.
P2860
Q26738664-1AFCDB32-89B4-4349-AFE3-9E54BD9F0552Q26741296-AE955FF5-9F81-4FC0-9553-EFEE162DA21DQ27312184-E5C6D136-17FF-47FB-BB83-C1B9A0FFD7F4Q28074931-C485C424-81C3-4F3E-8D59-B12B07745F43Q28116050-D249C5E3-324C-480B-81A8-C196ABE4A3DCQ33739682-0E31BC07-29E4-4931-A3BC-941A7D041915Q33739733-1F359230-55B5-4E9A-8FC8-F486880C41E6Q36055662-DC64DEB1-F3F0-4065-8480-8B533AEC1F2EQ36147466-5DE2E7B5-4DC8-49DF-8FAF-C87CBFD8CD96Q36347782-98D01084-3521-4D7C-9BC2-B5CC4DDE2B75Q37010219-0A493954-4770-45FD-91D2-AD223912433FQ37211004-8D082776-866A-40CD-ADA2-6B30B6B72C3AQ38679766-EB90CD75-ED8E-427F-9FDC-C83A0100E503Q38716866-30E3F8FD-F7E0-47DC-9066-7E1DE342EFB9Q38717741-F5EB2629-2BAC-4EDA-A144-B8E3CA6B82C2Q38726293-45818621-0AE7-4CFF-B621-00633A2EF468Q38735423-898C1E45-94B1-473E-BA80-FFEF462F9C54Q38815706-04EF9DBF-8F82-499B-8C87-F8D958CE2490Q39101108-811374DC-6BAD-4DE2-83FE-DF9E9915BAD8Q39185469-605912EC-B675-4031-8AFD-666B586368BFQ39256785-C934949B-7CCE-4278-9927-8309F3514388Q39295240-D55066E3-031B-443D-8CC6-8A726EADA7A3Q39301532-A37FE80D-EFC3-4212-9816-AEE27244FF47Q39432413-5A99E406-B258-4645-BE0F-57909DCF4C8EQ41387647-EAF0413D-4C97-455E-846B-782A01E7E2F1Q41856429-9DCEEFFC-1C12-41A2-8FF7-93ACC5FC6F05Q42282317-EFA68C99-56B2-4FAE-A6BE-1C5F14F408F2Q47129433-FCACCF65-A124-4152-9B6A-AAABC523842DQ47152662-EF6F0D7C-8EA2-4B4E-B493-02E176C25D9BQ47908310-00870083-06B9-43FC-81FC-C3EED49400FDQ47946104-2253E62F-E1DF-4C24-BDB1-378284624636Q48104981-94880D99-12C6-426C-94C3-3581841BCD85Q50880824-B8FCF94B-E1FA-4A8E-B9B8-A240CDF9BBE6Q51148325-0F244E06-45C4-4C9A-BA69-A86E3FDB7BE3Q52335114-C1ED5697-EDC2-4A1E-B4B4-BD4DAAD24075Q52666754-8F9C0C43-32F1-4761-B263-C3899F591823Q54252269-66AF9155-809E-4D4C-A66B-1B354208092BQ54971907-6BDE4D5F-0376-4BB4-910B-0D773D30066BQ54978916-6B75472B-3BCB-41AE-807E-7D5DDD84AD9EQ55114672-72027B39-D5A5-4794-9E9F-E5F0789EC508
P2860
Defective control of pre-messenger RNA splicing in human disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Defective control of pre-messenger RNA splicing in human disease
@ast
Defective control of pre-messenger RNA splicing in human disease
@en
Defective control of pre-messenger RNA splicing in human disease
@nl
type
label
Defective control of pre-messenger RNA splicing in human disease
@ast
Defective control of pre-messenger RNA splicing in human disease
@en
Defective control of pre-messenger RNA splicing in human disease
@nl
prefLabel
Defective control of pre-messenger RNA splicing in human disease
@ast
Defective control of pre-messenger RNA splicing in human disease
@en
Defective control of pre-messenger RNA splicing in human disease
@nl
P2860
P921
P3181
P356
P1476
Defective control of pre-messenger RNA splicing in human disease
@en
P2093
Benoit Chabot
Lulzim Shkreta
P2860
P3181
P356
10.1083/JCB.201510032
P407
P577
2016-01-04T00:00:00Z